SEO report of targetcdk.org
Targeting CDK 4/6 in Advanced Breast Cancer | Pfizer
targetcdk.org
Discover the latest breakthrough in treating advanced breast cancer by targeting cyclin dependent kinases (CDK) 4/6 in cancer cell cycle progression.
Discover the latest breakthrough in treating advanced breast cancer by targeting cyclin dependent kinases (CDK) 4/6 in cancer cell cycle progression.
Language
Declared Language Code
En
Detected Language Code
en
SSL checking
HTTPS
used
Social shares
All Social Shares
3
Facebook Shares
3
LinkedIN Shares
2
Content Report
Number of letters:
1135
Number of words:
247
Number of sentences:
15
Average words per sentences:
16
Number of syllables:
359
Syllables in words
354
Average syllables in words:
1.45
Number of words in first three syllables:
37
Percentage of word / syllables:
14.98
Readability
Readablitiy
- Flesch–Kincaid Grade Level: 8.00
- lesch Reading Ease: 67.20
- Coleman Liau Index: 11.20
- Automated Readability Index (ARI): 8.40
- Dale–Chall Readability: 8.30
- SMOG Index: 12.00
- Spache Readability: 5.00
- Words not in Dale-Chall easy-word list: 117
- Words not in Spache easy-word list: 68
Keywords (2 words) / counter
- "the science" / 5
- "breast cancer" / 4
- "expert insights" / 3
- "for updates" / 3
- "register for" / 3
- "and the" / 2
- "explore the" / 2
- "stats register" / 2
- "pathway watch" / 2
- "insights breast" / 2
Keywords (3 words) / counter
- "register for updates" / 3
- "stats register for" / 2
- "breast cancer stats" / 2
- "cancer stats register" / 2
- "insights breast cancer" / 2
- "expert insights breast" / 2
Important Meta Datas
Meta Title
Targeting CDK 4/6 in Advanced Breast Cancer | Pfizer
Meta Description
Discover the latest breakthrough in treating advanced breast cancer by targeting cyclin dependent kinases (CDK) 4/6 in cancer cell cycle progression.
Other Meta datas:
- Name:
Content: Targeting CDK 4/6 in Advanced Breast Cancer | Pfizer - Name: generator
Content: Drupal 7 (http://drupal.org) - Name: description
Content: Discover the latest breakthrough in treating advanced breast cancer by targeting cyclin dependent kinases (CDK) 4/6 in cancer cell cycle progression. - Name: viewport
Content: width=device-width, initial-scale=1.0, user-scalable=no - Name: MobileOptimized
Content: width - Name: HandheldFriendly
Content: true - Name: apple-mobile-web-app-capable
Content: yes - Name: format-detection
Content: telephone=no
Html Elements
- <div> : 144
- <a> : 26
- <meta> : 15
- <li> : 10
- <script> : 10
- <p> : 9
- <link> : 8
- <span> : 5
- <img> : 4
- <h2> : 2
- <section> : 2
- <ul> : 2
- <header> : 2
- <title> : 1
- <head> : 1
- <footer> : 1
- <style> : 1
- <body> : 1
- <html> : 1
- <label> : 1
- <h1> : 1
- <main> : 1
- <input> : 1
Html Classes
- <clearfix> : 37
- <block> : 21
- <block-content> : 20
- <no-title> : 20
- <block-inner> : 18
- <panel-pane> : 16
- <field-content> : 14
- <views-field> : 14
- <panel-separator> : 10
- <menu-depth-1> : 10
- <leaf> : 10
- <region> : 9
- <region-inner> : 8
- <pane-custom> : 7
- <views-row-odd> : 4
- <content> : 4
- <at-panel> : 4
- <panel-display> : 4
- <views-row> : 4
- <views-row-1> : 3
- <view-content> : 3
- <one-column> : 3
- <views-field-title> : 3
- <region-one-main> : 3
- <active> : 3
- <pane-block> : 3
- <view> : 3
- <views-row-first> : 3
- <pane-views> : 3
- <last> : 2
- <block-block> : 2
- <views-field-field-video-brightcove> : 2
- <bc-video-item> : 2
- <image-style-front-video> : 2
- <views-row-last> : 2
- <close-parent> : 2
- <video-attachment> : 2
- <views-field-field-video-next-link> : 2
- <views-field-body> : 2
- <first> : 2
- <visible-lg> : 2
- <view-mode-_custom_display> : 2
- <field-label-hidden> : 2
- <pane-palbo> : 2
- <field-items> : 2
- <block-panels-mini> : 2
- <even> : 2
- <field-item> : 2
- <menu> : 2
- <field> : 2
- <view-id-videos> : 1
- <view-videos> : 1
- <bc-indicator> : 1
- <view-display-id-hp_videos> : 1
- <view-dom-id-3e681eb3ffeaea99f8b376f48af1ed1e> : 1
- <field-name-body> : 1
- <field-type-text-with-summary> : 1
- <pane-videos> : 1
- <pane-node-body> : 1
- <view-dom-id-d9458464f70014ac141f9e8f2fe2a5fb> : 1
- <twitter> : 1
- <linkedin> : 1
- <facebook> : 1
- <block-title> : 1
- <pane-title> : 1
- <region-three-33-third> : 1
- <pane-4> : 1
- <pane-entity-field> : 1
- <pane-node-field-page-abbreviations> : 1
- <pane-6> : 1
- <pane-7> : 1
- <pane-5> : 1
- <region-footer> : 1
- <field-name-field-page-abbreviations> : 1
- <field-type-text> : 1
- <pane-3> : 1
- <region-three-33-second> : 1
- <three-3x33> : 1
- <region-three-33-first> : 1
- <pane-prefooter-callout> : 1
- <pane-panels-mini> : 1
- <views-row-even> : 1
- <pane-2> : 1
- <pane-dynamic-call-out> : 1
- <view-dynamic-call-out> : 1
- <image-style-none> : 1
- <views-field-field-page-callout-link-1> : 1
- <views-field-field-page-callout-image> : 1
- <front-video-block> : 1
- <view-id-dynamic_call_out> : 1
- <view-display-id-dynamic_callout> : 1
- <views-row-2> : 1
- <views_slideshow_slide> : 1
- <pane-system-main-menu> : 1
- <pane-system> : 1
- <pane-palbo-palbo-floodlight> : 1
- <region-header> : 1
- <branding-elements> : 1
- <h-group> : 1
- <menu-item-224> : 1
- <menu-item-454> : 1
- <pane-palbo-palbo-mobile-menu> : 1
- <hidden-lg> : 1
- <menu-item-457> : 1
- <menu-item-549> : 1
- <menu-item-455> : 1
- <page> : 1
- <container> : 1
- <page-node> : 1
- <page-node-> : 1
- <no-sidebars> : 1
- <not-logged-in> : 1
- <front> : 1
- <page-node-5> : 1
- <node-type-page> : 1
- <element-invisible> : 1
- <element-focusable> : 1
- <nocontent> : 1
- <atv-7.x-3.1+93-dev> : 1
- <atr-7.x-3.x> : 1
- <mobile-menu> : 1
- <mobile-menu-trigger> : 1
- <views-slideshow-cycle-main-frame-row-item> : 1
- <views-row-0> : 1
- <html> : 1
- <views_slideshow_cycle_slide> : 1
- <views_slideshow_cycle_teaser_section> : 1
- <views-slideshow-cycle-main-frame-row> : 1
- <views-field-field-slider-image> : 1
- <views-field-field-slider-headline> : 1
- <content-inner> : 1
- <block-system> : 1
- <content-column> : 1
- <columns> : 1
- <views-field-field-slider-copy> : 1
- <views-slideshow-cycle-main-frame> : 1
- <views_slideshow_main> : 1
- <menu-item-4053> : 1
- <menu-item-4052> : 1
- <menu-item-4050> : 1
- <menu-item-4049> : 1
- <menu-item-4048> : 1
- <pane-slider> : 1
- <view-slider> : 1
- <skin-default> : 1
- <views_slideshow_cycle_main> : 1
- <view-dom-id-5dd2252b860d9fa7317ebd13a15d5afe> : 1
- <view-display-id-slider_headline> : 1
- <view-id-slider> : 1
- <pane-1> : 1
Links
We found a total of 15 different links.
External dofollow links:
3
Internal dofollow links:
12
External dofollow
Number of External dofollow links: 3
- Href:
Title: Twitter
Count: 1 - Href:
Title: LinkedIn
Count: 1 - Href:
Title: Facebook
Count: 1
Internal dofollow
Number of Internal dofollow links: 12
- Href:
Title: Skip to main content
Count: 1 - Href: /
Title: The Science of Targeting CDK4/6
Count: 3 - Href: /cdk46-targeted-therapy-for-breast-cancer-research
Title: Science of CDK4/6
Count: 2 - Href: /expert-insights-estrogen-receptor-positive-breast-cancer-cure
Title: Expert Insights
Count: 2 - Href: /metastatic-breast-cancer-statistics
Title: Breast Cancer Stats
Count: 2 - Href: /registration-for-breast-cancer-news
Title: Register for Updates
Count: 4 - Href: /bc/4594095314001
Count: 1 - Href: /cdk46-targeted-therapy-for-breast-cancer-research
Title: Continue to the Science of CDK4/6 >
Count: 3 - Href:
Title: Close
Count: 2 - Href: /bc/4594095323001
Count: 1 - Href: /expert-insights-estrogen-receptor-positive-breast-cancer-cure
Title: Watch Other Expert Insights >
Count: 1 - Href:
Title: E-mail
Count: 1
Mistakes
argetcdk.org, trargetcdk.org, rargetcdk.org, tfargetcdk.org, fargetcdk.org, tgargetcdk.org, gargetcdk.org, thargetcdk.org, hargetcdk.org, tyargetcdk.org, yargetcdk.org, t5argetcdk.org, 5argetcdk.org, t6argetcdk.org, 6argetcdk.org, trgetcdk.org, taqrgetcdk.org, tqrgetcdk.org, tawrgetcdk.org, twrgetcdk.org, tazrgetcdk.org, tzrgetcdk.org, targetcdk.org, trgetcdk.org, taxrgetcdk.org, txrgetcdk.org, tasrgetcdk.org, tsrgetcdk.org, tagetcdk.org, taregetcdk.org, taegetcdk.org, tardgetcdk.org, tadgetcdk.org, tarfgetcdk.org, tafgetcdk.org, targgetcdk.org, taggetcdk.org, tar4,getcdk.org, ta4,getcdk.org, tartgetcdk.org, tatgetcdk.org, tar5getcdk.org, ta5getcdk.org, taretcdk.org, targretcdk.org, tarretcdk.org, targfetcdk.org, tarfetcdk.org, targvetcdk.org, tarvetcdk.org, targcetcdk.org, tarcetcdk.org, targbetcdk.org, tarbetcdk.org, targyetcdk.org, taryetcdk.org, targhetcdk.org, tarhetcdk.org, targnetcdk.org, tarnetcdk.org, targtcdk.org, targewtcdk.org, targwtcdk.org, targestcdk.org, targstcdk.org, targetcdk.org, targtcdk.org, targedtcdk.org, targdtcdk.org, targeftcdk.org, targftcdk.org, targertcdk.org, targrtcdk.org, targe3tcdk.org, targ3tcdk.org, targe4tcdk.org, targ4tcdk.org, targecdk.org, targetrcdk.org, targercdk.org, targetfcdk.org, targefcdk.org, targetgcdk.org, targegcdk.org, targethcdk.org, targehcdk.org, targetycdk.org, targeycdk.org, target5cdk.org, targe5cdk.org, target6cdk.org, targe6cdk.org, targetdk.org, targetcxdk.org, targetxdk.org, targetcsdk.org, targetsdk.org, targetcdk.org, targetdk.org, targetcddk.org, targetddk.org, targetcfdk.org, targetfdk.org, targetcvdk.org, targetvdk.org, targetc dk.org, target dk.org, targetck.org, targetcdxk.org, targetcxk.org, targetcdsk.org, targetcsk.org, targetcdwk.org, targetcwk.org, targetcdek.org, targetcek.org, targetcdrk.org, targetcrk.org, targetcdfk.org, targetcfk.org, targetcdvk.org, targetcvk.org, targetcdck.org, targetcck.org, targetcd.org, targetcdku.org, targetcdu.org, targetcdkj.org, targetcdj.org, targetcdkm.org, targetcdm.org, targetcdkl.org, targetcdl.org, targetcdko.org, targetcdo.org